Pacific Biosciences of California, Inc.
PACB
$1.33
$0.064.72%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -28.32% | -36.61% | -38.26% | -38.94% | -38.24% |
| Total Receivables | 28.79% | 4.20% | -0.54% | 4.36% | -24.83% |
| Inventory | -16.12% | -19.14% | -21.51% | -19.80% | 3.67% |
| Prepaid Expenses | -42.53% | -33.36% | -27.71% | -9.76% | 10.22% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -97.10% | -56.52% | -12.28% | 130.00% | 130.00% |
| Total Current Assets | -24.34% | -32.52% | -34.19% | -34.28% | -33.20% |
|
|
|||||
| Total Current Assets | -24.34% | -32.52% | -34.19% | -34.28% | -33.20% |
| Net Property, Plant & Equipment | 41.30% | 31.27% | 16.24% | 1.82% | -32.49% |
| Long-term Investments | 0.00% | -13.90% | -13.90% | -31.26% | -31.26% |
| Goodwill | 0.00% | -13.90% | -13.90% | -31.26% | -31.26% |
| Total Other Intangibles | -96.12% | -96.30% | -96.13% | -95.96% | -14.75% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -4.91% | -6.59% | -9.98% | -14.51% | -30.96% |
| Total Assets | -37.79% | -44.61% | -45.31% | -48.45% | -27.81% |
|
|
|||||
| Total Accounts Payable | 25.20% | 35.63% | -13.91% | -33.18% | 10.14% |
| Total Accrued Expenses | 25.42% | 23.11% | -7.14% | 6.76% | -51.93% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -95.53% | -66.08% | -70.35% | -45.42% | -0.55% |
| Total Finance Division Other Current Liabilities | 35.56% | 8.49% | -22.40% | 18.17% | -27.72% |
| Total Other Current Liabilities | 35.56% | 8.49% | -22.40% | 18.17% | -27.72% |
| Total Current Liabilities | 9.85% | 5.35% | -23.77% | -8.70% | -30.23% |
|
|
|||||
| Total Current Liabilities | 9.85% | 5.35% | -23.77% | -8.70% | -30.23% |
| Long-Term Debt | -0.33% | -27.77% | -27.60% | -27.60% | -27.43% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 279.46% | 220.68% | 165.45% | 73.78% | -52.81% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -84.38% | -83.62% | -77.99% | -77.79% | -2.65% |
| Total Liabilities | 3.30% | -23.06% | -24.86% | -24.66% | -27.84% |
|
|
|||||
| Common Stock & APIC | 1.70% | 3.37% | 3.65% | 3.88% | 4.52% |
| Retained Earnings | -25.43% | -23.41% | -25.18% | -34.31% | -16.85% |
| Treasury Stock & Other | 8.29% | -73.28% | 151.05% | 224.51% | 92.69% |
| Total Common Equity | -98.94% | -92.04% | -87.52% | -85.88% | -27.76% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -98.94% | -92.04% | -87.52% | -85.88% | -27.76% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -98.94% | -92.04% | -87.52% | -85.88% | -27.76% |
|
|
|||||